Clearpoint Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Clearpoint Neuro
CLPT Stock  USD 14.92  0.39  2.55%   
Analyzing historical trends in various income statement and balance sheet accounts from Clearpoint Neuro's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Clearpoint Neuro's valuation are summarized below:
Gross Profit
21.1 M
Profit Margin
(0.67)
Market Capitalization
455.4 M
Enterprise Value Revenue
13.1938
Revenue
34.3 M
There are currently one hundred twenty fundamental signals for Clearpoint Neuro that can be evaluated and compared over time across rivals. All traders should validate Clearpoint Neuro's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 392.8 M in 2026. Enterprise Value is likely to gain to about 377.2 M in 2026

Clearpoint Neuro Total Revenue

37.9 Million

Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 330 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 15.47. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Build AI portfolio with Clearpoint Stock
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Clearpoint Neuro Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding32.6 M31.1 M12.8 M
Slightly volatile
Total Assets24.6 M45.1 M22.7 M
Slightly volatile
Short and Long Term Debt Total3.9 M4.1 M8 M
Very volatile
Other Current Liabilities7.6 M7.3 M3.5 M
Slightly volatile
Total Current Liabilities5 M9.3 M6.8 M
Slightly volatile
Property Plant And Equipment Net6.1 M5.9 M2.2 M
Slightly volatile
Current Deferred Revenue2.6 M2.4 M1.2 M
Slightly volatile
Accounts Payable890 K1.2 M1.3 M
Slightly volatile
Cash14.6 M23.1 M13.2 M
Slightly volatile
Non Current Assets Total7 M6.7 M3.2 M
Slightly volatile
Non Currrent Assets Other214.6 K225.9 K614 K
Pretty Stable
Cash And Short Term Investments15.4 M23.1 M13.8 M
Slightly volatile
Net Receivables5.7 M5.4 M2 M
Slightly volatile
Common Stock Total Equity263.6 K221.4 K299.7 K
Slightly volatile
Liabilities And Stockholders Equity24.6 M45.1 M22.7 M
Slightly volatile
Non Current Liabilities Total3.8 M4 M7.9 M
Very volatile
Inventory8.3 M7.9 M3.9 M
Slightly volatile
Other Current Assets2 M1.9 M626.7 K
Slightly volatile
Other Stockholder Equity144.7 M249 M136.7 M
Slightly volatile
Total Liabilities16 M15.9 M15.4 M
Very volatile
Property Plant And Equipment Gross7.8 M7.4 M2.6 M
Slightly volatile
Total Current Assets21.6 M38.4 M19.8 M
Slightly volatile
Short Term Debt476.2 K501.3 K1.7 M
Slightly volatile
Common Stock255.8 K248.4 K302.7 K
Slightly volatile
Intangible Assets574.5 K435.6 K592 K
Slightly volatile
Other Assets1.3 M668.1 K1 M
Very volatile
Long Term Debt8.3 M11.4 M6.8 M
Slightly volatile
Long Term Debt Total7.9 M11.4 M6.8 M
Slightly volatile
Capital Surpluse137.6 M215.1 M126.2 M
Slightly volatile
Property Plant Equipment1.3 M1.4 M986.4 K
Slightly volatile
Other Liabilities505.7 K351 K585.1 K
Slightly volatile
Net Invested Capital28.6 M29.2 M20.1 M
Slightly volatile
Short and Long Term Debt1.6 M1.8 M2 M
Slightly volatile
Net Working Capital26.8 M26.5 M18 M
Slightly volatile
Capital Stock226.1 K317.4 K168.4 K
Slightly volatile
Capital Lease Obligations2.8 M4.1 M1.5 M
Slightly volatile
Deferred Long Term Liabilities318.6 K448.5 K268.6 K
Slightly volatile
Non Current Liabilities Other1.6 M1.4 M2.1 M
Slightly volatile

Clearpoint Neuro Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.3 M2.2 M738.3 K
Slightly volatile
Interest Expense330 K347.4 K1 M
Slightly volatile
Selling General Administrative7.5 M13.8 M7.3 M
Slightly volatile
Total Revenue37.9 M36.1 M13.8 M
Slightly volatile
Gross Profit23.1 M22 M8.7 M
Slightly volatile
Other Operating Expenses61.7 M58.8 M25 M
Slightly volatile
Research Development15 M14.3 M6.4 M
Slightly volatile
Cost Of Revenue14.8 M14.1 M5.1 M
Slightly volatile
Total Operating Expenses46.9 M44.7 M19.9 M
Slightly volatile
Interest Income672.6 K1 M504.9 K
Slightly volatile
Selling And Marketing Expenses17.5 M16.6 M7.2 M
Slightly volatile
Reconciled Depreciation2.3 M2.2 M609 K
Slightly volatile

Clearpoint Neuro Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8.3 M7.9 M2.8 M
Slightly volatile
Begin Period Cash Flow27.9 M26.6 M13.2 M
Slightly volatile
Depreciation2.3 M2.2 M741.8 K
Slightly volatile
Capital Expenditures202.5 K316.2 K192.9 K
Slightly volatile
End Period Cash Flow13.8 M23.1 M13.2 M
Slightly volatile
Change To Netincome4.8 M4.6 M2.1 M
Slightly volatile
Dividends Paid254.4 K183.6 K366.7 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.3611.929.2494
Pretty Stable
Days Sales Outstanding43.0349.3251.988
Very volatile
Average Payables688.5 K724.7 K1.2 M
Slightly volatile
Stock Based Compensation To Revenue0.230.250.2162
Pretty Stable
Capex To Depreciation0.120.130.4302
Pretty Stable
EV To Sales10.4714.629.611
Pretty Stable
Inventory Turnover0.881.611.0941
Slightly volatile
Days Of Inventory On Hand394235364
Slightly volatile
Payables Turnover6.068.247.0848
Slightly volatile
Sales General And Administrative To Revenue0.550.440.5824
Slightly volatile
Average Inventory1.2 M1.6 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.690.450.6192
Slightly volatile
Capex To Revenue0.00750.00790.0203
Very volatile
Cash Per Share0.810.861.5177
Pretty Stable
Days Payables Outstanding43.5645.85420
Slightly volatile
Income Quality0.990.540.8855
Slightly volatile
Intangibles To Total Assets0.01350.01420.0469
Slightly volatile
Current Ratio2.992.93.4314
Slightly volatile
Receivables Turnover8.047.667.502
Pretty Stable
Capex Per Share0.01110.01170.0448
Slightly volatile
Average Receivables684.5 K982.5 K922.5 K
Slightly volatile
Revenue Per Share1.271.342.389
Slightly volatile
Interest Debt Per Share0.140.154.8785
Slightly volatile
Debt To Assets0.09950.10.7053
Slightly volatile
Operating Cycle454298418
Slightly volatile
Days Of Payables Outstanding43.5645.85420
Slightly volatile
Ebt Per Ebit1.221.11.1168
Pretty Stable
Quick Ratio2.462.32.8212
Slightly volatile
Cash Ratio2.071.752.36
Slightly volatile
Days Of Inventory Outstanding394235364
Slightly volatile
Days Of Sales Outstanding43.0349.3251.988
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.820.931.0095
Pretty Stable
Fixed Asset Turnover7.785.558.9699
Very volatile
Debt Ratio0.09950.10.7053
Slightly volatile
Price Sales Ratio7.3611.929.2494
Pretty Stable
Asset Turnover0.70.920.6984
Slightly volatile
Gross Profit Margin0.740.70.6787
Slightly volatile

Clearpoint Neuro Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap392.8 M374.1 M142.6 M
Slightly volatile
Enterprise Value377.2 M359.2 M135.5 M
Slightly volatile

Clearpoint Fundamental Market Drivers

Clearpoint Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.4 M2.6 M
Total Revenue36.1 M37.9 M
Cost Of Revenue14.1 M14.8 M
Stock Based Compensation To Revenue 0.25  0.23 
Sales General And Administrative To Revenue 0.44  0.55 
Research And Ddevelopement To Revenue 0.45  0.69 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.34  1.27 
Ebit Per Revenue(0.57)(0.59)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY